2023

Hui-Ju Tseng, Wen-Chu Chen, Tien-Fen Kuo, Greta Yang, Ching-Shan Feng, Hui-Ming Chen , Tzung-Yan Chen, Tsung-Han Lee, Wen-Chin Yang, Keng-Chang Tsai, Wei-Jan Huang

Pharmacological and mechanistic study of PS1, a Pdia4 inhibitor, in beta-cell pathogenesis and diabetes in db/db mice. CELLULAR AND MOLECULAR LIFE SCIENCES , 80, 101

Sunny Mai; Alan Hodges; Hui-Ming Chen ; Jilu Zhang; Yi-Ling Wang; Yongbin Liu; Fumiko Nakatsu; Xiaoxuan Wang; Jing Fang; Yitian Xu; Vitaliy Davidov; Kyeongah Kang; Sai Ravi Pingali; Siddhartha Ganguly; Masataka Suzuki; Marina Konopleva; Brooke Prinzing; Youli Zu; Stephen Gottschalk; Yong Lu ; Shu-Hsia Chen ; Ping-Ying Pan

LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. CANCER RESEARCH , 83, 4047

Sunny Mai, Alan Hodges, Hui-Ming Chen , Jilu Zhang, Yi-Ling Wang, Yongbin Liu, Fumiko Nakatsu, Xiaoxuan Wang, Jing Fang, Yitian Xu, Vitaliy Davidov, Kyeongah Kang, Sai Ravi Pingali Siddhartha Ganguly, Masataka Suzuki, Marina Konopleva, Brooke Prinzing, Youli Zu, Stephen Gottschalk , Yong Lu, Shu-Hsia Chen , Ping-Ying Pan

LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Research , 4047-4062

2021

Tai-Na Wu, Hui-Ming Chen , Lie-Fen Shyur

Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , 22(24), 13571

Chen Hui-Ming , Sun Linus, Pan Ping-Ying, Wang Lu-Hai, Chen Shu-Hsia

Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism. Cancer Immunology, Immunotherapy , 70(12), 3435-3449

2019

Zhang J,* Hui-Ming Chen *, Ma G, Zhou Z., Raulet D., Chen S. –H., Pan P. –Y. *: Equal contribution

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.. Leukemia , 33, p2078–2089.

2018

Hui-Ming Chen .*, van der Touw, W.*, Wang, Y.S., Kang, K., Mai, S., Zhang, J., Alsina-Beauchamp, D., Duty, J.A., Mungamuri, S.K., Zhang, B., Moran, T., Flavell, R., Aaronson, S., Hu, H.M., Arase, H., Ramanathan, S., Flores, R., Pan, P.Y., & Chen, S.H. *: Equal contribution.

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity. The Journal of Clinical Investigation , 128(12), p5647-5662. PMCID: PMC6264729.

2017

Zhang, J., Mai, S., Hui-Ming Chen , Kang, K., Li, X.C., Chen S.H., & Pan P.Y.

Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies. Journal of Leukocyte Biology , 102(2), p351-360. PMCID: PMC5505746

van der Touw, W., Hui-Ming Chen , Pan. P.Y., & Chen, S.H.

LILRB receptor-mediated regulation of myeloid cell maturation and function. Cancer Immunology Immunotherapy , 66(8), p1079-1087. PMCID: PMC5591173

4. Kuo, T.F., Chen, T.Y., Jiang, S.T., Chen, K.W., Chiang, Y.M., Hsu, Y.J., Liu, Y.J., Hui-Ming Chen , Yokoyama, K.K., Tsai K.C., Yeh, H.H., Chen, Y.R., Yang, M.T., Yang, C.Y., & Yang, W.C.

Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway. Oncogene , 36(39), p5484-5496. PMID: 28534513

2015

Hui-Ming Chen *, Ma, G.*, Gildener-Leapman, N., Eisenstein, S., Coakley, B.A., Ozao, J., Mandeli, J., Divino, C., Schwartz, M., Sung, M., Ferris, R., Kao, J., Wang, L.H., Pan, P.Y., Ko, E.C, & Chen, S.H. *: Equal contribution.

Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy. Clinical Cancer Research , 21(18), p4073-4085. PMCID: PMC4720266

6. Conde, P., Rodriguez, M., van der Touw, W., Jimenez, A., Burns, M., Miller, J., Brahmachary, M., Hui-Ming Chen , Boros, P., Rausell-Palamos, F., Yun, T.J., Riquelme, P., Rastrojo, A., Aguado, B., Stein-Streilein, J., Tanaka, M., Zhou, L., Zhang, J., Lowary, T.L., Ginhoux, F., Park, C.G., Cheong, C., Brody, J., Turley, S.J., Lira, S.A., Bronte, V., Gordon, S., Heeger, P.S., Merad, M., Hutchinson, J., Chen, S.H., & Ochando, J.

DC-SIGN(+) macrophages control the induction of transplantation tolerance. Immunity , 42(6), p1143-58

2013

7. Eisenstein, S., Coakley, B.A., Briley-Saebo, K., Ma, G., Hui-Ming Chen ., Meseck, M., Ward, S., Divino, C., Woo, S., Chen, S.H., & Pan, P.Y.

Myeloid derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy. Cancer Research , 73(16), p5003-5015. PMCID: PMC3745543.

Chang Wei-Ting, Chen Hui-Ming , Yin Shu-Yi, Chen Yung-Hsiang, Wen Chih-Chun, Wei Wen-Chi, Lai Phoency, Wang Cheng-Hsin, Yang Ning-Sun

Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines. Evidence-Based Complementary and Alternative Medicine , 2013, 932040

2012

Chen Hui-Ming , Wang Pi-Hsueh, Chen Swey-Shen, Wen Chih-Chun, Chen Yun-Hsiang, Yang Wen-Chin, Yang Ning-Sun

Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunology Immunotherapy , 61(11), 1989-2002

Chen Hui-Ming , Wang Pi-Hsueh, Aravindaram Kandan, Chen Yun-Hsiang, Yu Hsiu-Hui, Yang Wen-Chin, Yang Ning-Sun

Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES. Journal of Biomedical Science , 19(1), 42

C L T Chang, Yi-Ching Chen, Hui-Ming Chen , Ning-Sun Yang, Wen-Chin Yang

Natural cures for type 1 diabetes: a review of phytochemicals, biological actions, and clinical potential. Curr Med Chem , 20(7), 899-907

2011

Wen Chih-Chun, Chen Hui-Ming , Chen Swey-Shen, Huang Li-Ting, Chang Wei-Ting, Wei Wen-Chi, Chou Li-Chen, Arulselvan Palanisamy, Wu Jin-Bin, Kuo Sheng-Chu, Yang Ning-Sun

Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines. Journal of Biomedical Science , 18(1), 44

2009

Aravindaram K, Yu H-H, Lan C-W, Wang P-H, Chen Y-H, Hui-Ming Chen , Yagita H, Yang N-S

Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma. Gene Therapy , 16(11), 1329-1339